Pei Y Liu

发表

The regulatory role of long noncoding RNAs in cancer.

M. Dinger, G. Marshall, Ying Tang, 2017, Cancer letters.

The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35

Leming Shi, J. Vandesompele, M. Fischer, 2019, Nature Communications.

The Critical Role of RNA m6A Methylation in Cancer.

Q. Lan, S. Hüttelmaier, Jacob Haase, 2019, Cancer research.

SIRT1 Promotes N-Myc Oncogenesis through a Positive Feedback Loop Involving the Effects of MKP3 and ERK on N-Myc Protein Stability

A. Biankin, C. Scarlett, G. Perini, 2011, PLoS genetics.

The RNA‐helicase DDX21 upregulates CEP55 expression and promotes neuroblastoma

M. Kavallaris, J. McCarroll, M. Haber, 2021, Molecular oncology.

The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects

J. Bradner, R. Lock, G. Marshall, 2016, Clinical Cancer Research.

Targeting I k B Kinase b /NF- k B Signaling in Human Prostate Cancer by a Novel I k B Kinase b Inhibitor CmpdA

Han C. Dan, A. Hussain, Xuefeng Liu, 2016 .

VASP Activation via the Gα13/RhoA/PKA Pathway Mediates Cucurbitacin-B-Induced Actin Aggregation and Cofilin-Actin Rod Formation

D. Ouyang, Xian-hui He, Q. Lu, 2014, PloS one.

The Emerging Roles of RNA m6A Methylation and Demethylation as Critical Regulators of Tumorigenesis, Drug Sensitivity, and Resistance

Q. Lan, Xu Dong Zhang, Lirong Zhang, 2021, Cancer Research.

The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1.

E. Pasquier, Takayoshi Suzuki, M. Dinger, 2014 .

WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma.

R. C. Poulos, J. W. Wong, C. Arrowsmith, 2015, Cancer research.

Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis

G. Perini, G. Della Valle, M. Haber, 2007, Proceedings of the National Academy of Sciences.

A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers.

J. George, A. deFazio, D. Bowtell, 2017, Cancer research.

Delineation of the frequency and boundary of chromosomal copy number variations in paediatric neuroblastoma

Jinyan Li, C. Mayoh, G. Marshall, 2018, Cell cycle.

JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma

R. C. Poulos, J. W. Wong, M. Fischer, 2019, Nature Communications.

Upregulation of LYAR induces neuroblastoma cell proliferation and survival

I. Mungrue, Bing Liu, M. Wong, 2017, Cell Death and Differentiation.

The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription.

R. C. Poulos, C. Scarlett, J. Wong, 2017, Cancer research.

The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs

M. Dinger, S. Guo, Xu Dong Zhang, 2016, Oncotarget.

NCYM is upregulated by lncUSMycN and modulates N-Myc expression.

Tao Liu, Pei Y. Liu, B. Atmadibrata, 2016, International journal of oncology.

Enhancing the anticancer effect of the histone deacetylase inhibitor by activating transglutaminase.

S. Iismaa, N. Xu, G. Marshall, 2012, European journal of cancer.

Neuroblastoma: A Malignancy Due to Cell Differentiation Block

Tao Liu, G. Marshall, Tao Liu, 2012 .

Opposing Effects of Two Tissue Transglutaminase Protein Isoforms in Neuroblastoma Cell Differentiation*

M. Haber, M. Norris, S. Iismaa, 2009, The Journal of Biological Chemistry.

Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression.

J. Mattick, M. Dinger, A. Fox, 2014, Journal of the National Cancer Institute.

The Novel Long Noncoding RNA linc00467 Promotes Cell Survival but Is Down-Regulated by N-Myc

G. Marshall, M. Wong, Tao Liu, 2014, PloS one.

The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1

E. Pasquier, Takayoshi Suzuki, M. Dinger, 2014, Oncotarget.

Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy

H. Pickett, J. Vandesompele, M. Fischer, 2020, Clinical Cancer Research.

Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors.

M. Gleave, M. Haber, M. Norris, 2009, European journal of cancer.

The critical role of the class III histone deacetylase SIRT1 in cancer.

G. Marshall, Tao Liu, Pei Y. Liu, 2009, Cancer research.

The Histone Demethylase NO66 Induces Glioma Cell Proliferation

Q. Lan, Tao Liu, Pei Y. Liu, 2019, AntiCancer Research.

Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastoma.

J. Fletcher, G. Marshall, M. Wong, 2020, International journal of cancer.